Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Telix Pharmaceuticals Ltd Director's Dealing 2025

May 21, 2025

31324_rns_2025-05-21_c97e0605-f0a3-44fd-8ea1-e07da4e2d6a1.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity Telix Pharmaceuticals Limited ABN 85 616 620 369

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director Harry Kevin McCann
Date of last notice 5 March 2025
Date that director ceased to be director 21 May 2025

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of securities Note: Provide details of the circumstances giving rise to the relevant interest Monjoy Pty Limited, of which Harry 130,000 fully paid ordinary shares Kevin McCann is a director, as Trustee for the HK McCann Family Trust. Cottesloe Pty Limited of which 990,000 fully paid ordinary shares Harry Kevin McCann is a director and substantial shareholder.

Part 3 – Director’s interests in contracts

Detail of contract Not applicable.
Nature of interest Not applicable.
Name of registered holder Not applicable.
(if issued securities)
No. and class of securities to which Not applicable.
interest relates
  • See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002